LymeNet Home LymeNet Home Page LymeNet Flash Discussion LymeNet Support Group Database LymeNet Literature Library LymeNet Legal Resources LymeNet Medical & Scientific Abstract Database LymeNet Newsletter Home Page LymeNet Recommended Books LymeNet Tick Pictures Search The LymeNet Site LymeNet Links LymeNet Frequently Asked Questions About The Lyme Disease Network LymeNet Menu

LymeNet on Facebook

LymeNet on Twitter




The Lyme Disease Network receives a commission from Amazon.com for each purchase originating from this site.

When purchasing from Amazon.com, please
click here first.

Thank you.

LymeNet Flash Discussion
Dedicated to the Bachmann Family

LymeNet needs your help:
LymeNet 2020 fund drive


The Lyme Disease Network is a non-profit organization funded by individual donations.

LymeNet Flash Post New Topic  New Poll  Post A Reply
my profile | directory login | register | search | faq | forum home

  next oldest topic   next newest topic
» LymeNet Flash » Questions and Discussion » Medical Questions » Mumps, Rubella, Parvovirus, and Poxvirus: Parvovirus

 - UBBFriend: Email this page to someone!    
Author Topic: Mumps, Rubella, Parvovirus, and Poxvirus: Parvovirus
AliG
Frequent Contributor (1K+ posts)
Member # 9734

Icon 2 posted      Profile for AliG     Send New Private Message       Edit/Delete Post   Reply With Quote 
Interesting info on Parvovirus as the cause of other previously familiar diseases?:

Measles, Mumps, Rubella, Parvovirus, and Poxvirus: Parvovirus

From ACP Medicine Online
Posted 06/07/2006
Martin S. Hirsch, M.D.

Although only recently recognized as a human pathogen, parvovirus B19 is now appreciated as a cause of several syndromes in both children and adults.

Parvovirus B19, a small (20 to 26 nm), single-stranded DNA virus, causes erythema infectiosum (fifth disease) in normal persons, aplastic crises in persons with underlying hemolytic disorders, chronic anemia in immunocompromised hosts, and fetal loss in pregnant women.36-40


Epidemiology

Parvovirus B19 infection occurs most commonly in school-age children in outbreaks during late winter and spring.

Only 2% to 15% of pre-school-age children have antibodies, but seroprevalence increases to 35% to 60% by 11 to 19 years of age and to greater than 75% in persons older than 50 years.41

Respiratory transmission is likely and is facilitated by close contact.

Hospital outbreaks have also been described and are often traced to patients with aplastic crises who carry large amounts of virus in blood and respiratory secretions.42,43

Maternal infection can lead to fetal anemia, hydrops fetalis, heart failure, and death, resulting in spontaneous abortion, most commonly 4 to 6 weeks after infection.

When women are infected during the first 20 weeks of pregnancy, the risk of parvovirus-related fetal death is approximately 9% to 10%.44,45 Routine antenatal screening is not recommended.38,46


Pathogenesis

Replication of parvovirus B19 has been demonstrated in human erythroid progenitor cells, and the receptor appears to be the P blood group antigen globoside, a neutral glycosphingolipid, which occurs in erythrocytes, erythroblasts, megakaryocytes, endothelial cells, placenta, and fetal liver and heart cells.47

Expression of this glycosphingolipid in tissues helps to determine parvovirus B19 tropism.48

Persons who lack erythrocyte P antigen (p phenotype) are naturally resistant to infection,37,49 and the distribution of parvovirus in infected individuals is linked to the presence of the P antigen.

Although little is known about the pathogenesis of parvovirus, antiviral antibodies--particularly those directed against the capsid protein VP1--appear to be responsible for viral clearance.

The presence of certain HLA class I and class II alleles may be associated with more symptomatic parvovirus infections.50

Diagnosis

Clinical Features

The rash caused by parvovirus B19, erythema infectiosum, usually appears without prodromal symptoms after an incubation period of 4 to 14 days.

The exanthem progresses through three stages. Initially, a fiery-red rash develops on both cheeks (giving them the appearance of having been slapped), accompanied by relative pallor around the mouth. >From 1 to 4 days later, an erythematous maculopapular eruption appears on the proximal extremities and spreads to the trunk in a lacelike, reticular pattern. The third stage, during which the eruption waxes and wanes, may persist for several weeks and may be precipitated by skin trauma, exposure to sunlight, or extremes of temperature.

Arthralgia and arthritis are seen in up to 80% of infected adults; arthralgia is particularly common in women, may occur without rash, and may linger for weeks.

Joint involvement is often symmetrical in the hands, wrists, knees, and ankles. Hemolytic anemias and encephalopathies are rare complications.


Laboratory Tests

Parvovirus-specific IgM antibodies usually appear within 3 days after symptoms develop; these antibodies persist for several weeks and then rapidly decline.

IgG antibodies, however, persist for years. Viral DNA can also be detected in blood, tissues, and secretions, although culture techniques for virus isolation are unsatisfactory.


Complications

Transient aplastic crises associated with parvovirus B19 occur in patients who have sickle cell anemia, hereditary spherocytosis, thalassemia, and various other hemolytic anemias.51

These aplastic crises are abrupt in onset and associated with giant pronormoblasts in the bone marrow.

They generally last 1 to 2 weeks and go into remission spontaneously. In immunocompromised hosts (e.g., patients with HIV infection), acute infection may lead to viral persistence and chronic bone marrow suppression.40

A significant proportion of patients with AIDS who develop severe anemia while receiving zidovudine (AZT) have persistent parvovirus infection.51

Pneumonia, hepatitis, and myocarditis have also been associated with parvovirus infections in immunocompromised as well as immunocompetent adults and children.52-57

Although parvovirus B19 has been implicated in a variety of rheumatic diseases, there is no definitive evidence for a causal role.


Treatment

Pooled human immune globulin contains anti-parvovirus B19 antibodies and has been used to treat persistent infections as well as acute exposures.40

Prevention of nosocomial infections is of great concern: pregnant health care workers should not care for patients with aplastic crises.

Droplet isolation is recommended for such patients, including the use of gowns, gloves, and masks during close contact.

Because certain blood products (e.g., clotting factors) contain parvovirus B19 DNA, screening of products, donors, and recipients has been suggested.58

Click here to subscribe or purchase the full chapter. Hirsch, Martin S, 7 Infectious Disease, XXIX Measles, Mumps, Rubella, Parvovirus, and Poxvirus, ACP Medicine Online, Dale DC; Federman DD, Eds. WebMD Inc., New York, 2000. http://www.acpmedicine.com/
Disclaimer

Figures, tables, references and sidebars are available in the subscription edition of ACP Medicine .


Martin S. Hirsch, M.D., Professor of Medicine, Harvard Medical School, Physician, Massachusetts General Hospital


ACP Medicine Online. 2002; �2002 WebMD Inc.

[ 08. January 2008, 12:17 PM: Message edited by: AliG ]

--------------------
Note: I'm NOT a medical professional. The information I share is from my own personal research and experience. Please do not construe anything I share as medical advice, which should only be obtained from a licensed medical practitioner.

Posts: 4881 | From Middlesex County, NJ | Registered: Jul 2006  |  IP: Logged | Report this post to a Moderator
JRWagner
Frequent Contributor (1K+ posts)
Member # 3229

Icon 1 posted      Profile for JRWagner     Send New Private Message       Edit/Delete Post   Reply With Quote 
Thanks Ali...I guess Parvo is not just for Dogs anymore.

Perhaps I should also be checked for WORMS!!!??

Na...

Peace, Love and Wellness,
JRW

Posts: 1414 | From Ny, Ny | Registered: Oct 2002  |  IP: Logged | Report this post to a Moderator
AliG
Frequent Contributor (1K+ posts)
Member # 9734

Icon 1 posted      Profile for AliG     Send New Private Message       Edit/Delete Post   Reply With Quote 
I found this:

Wadsworth Center, Department of Health, New York State

Disease Carriers
Viruses: Human Parvovirus B19


The most common manifestation of human parvovirus B19 infections is erythema infectiosm ("Fifth Disease"). This is characterized by mild symptoms, fever (in some patients) and a red rash on the face ("slapped cheek"). Arthralgia and arthritis have been seen occasionally in children and commonly in adults (particularly women).

However, human parvovirus B19 can also result in chronic infections in immunocompromised patients, and produce aplastic crisis in people with sickle-cell disease. Infection during pregnancy can cause fetal hydrops and fetal death (less than 10%).

Transmission is believed to be through respiratory secretions between humans, the only known reservoir for parvovirus B19. There are no known therapies; in most cases, supportive care is all that is required.


Human Parvovirus B19
 -
A negatively stained preparation of parvovirus as seen by transmission electron microscopy. The individual virions have a diameter of only 22nm. (nm=one-millionth of a millimeter)

* Clinical Virology Program - Virus Reference and Surveillance Laboratory (VRSL)- Parvovirus B19
* Learn more about Fifth Disease.

--------------------
Note: I'm NOT a medical professional. The information I share is from my own personal research and experience. Please do not construe anything I share as medical advice, which should only be obtained from a licensed medical practitioner.

Posts: 4881 | From Middlesex County, NJ | Registered: Jul 2006  |  IP: Logged | Report this post to a Moderator
   

Quick Reply
Message:

HTML is not enabled.
UBB Code� is enabled.

Instant Graemlins
   


Post New Topic  New Poll  Post A Reply Close Topic   Feature Topic   Move Topic   Delete Topic next oldest topic   next newest topic
 - Printer-friendly view of this topic
Hop To:


Contact Us | LymeNet home page | Privacy Statement

Powered by UBB.classic™ 6.7.3


The Lyme Disease Network is a non-profit organization funded by individual donations. If you would like to support the Network and the LymeNet system of Web services, please send your donations to:

The Lyme Disease Network of New Jersey
907 Pebble Creek Court, Pennington, NJ 08534 USA


| Flash Discussion | Support Groups | On-Line Library
Legal Resources | Medical Abstracts | Newsletter | Books
Pictures | Site Search | Links | Help/Questions
About LymeNet | Contact Us

© 1993-2020 The Lyme Disease Network of New Jersey, Inc.
All Rights Reserved.
Use of the LymeNet Site is subject to Terms and Conditions.